Compare SIFY & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIFY | OPK |
|---|---|---|
| Founded | 1995 | 2006 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 1.0B |
| IPO Year | 1999 | 2011 |
| Metric | SIFY | OPK |
|---|---|---|
| Price | $12.59 | $1.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.15 |
| AVG Volume (30 Days) | 27.7K | ★ 3.7M |
| Earning Date | 10-28-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $66.06 | N/A |
| Revenue Next Year | $18.27 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.09 | $0.98 |
| 52 Week High | $17.85 | $1.77 |
| Indicator | SIFY | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 56.68 |
| Support Level | $12.10 | $1.10 |
| Resistance Level | $14.38 | $1.75 |
| Average True Range (ATR) | 0.48 | 0.09 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 75.87 | 69.15 |
Sify Technologies Ltd is the integrated information and communication technology (ICT) solutions and services companies in India, offering end-to-end solutions with a comprehensive Product offering delivered over a common network infrastructure. It is providing services to enterprise customers, comprising Network services, Data Center services, and Digital Services which represent its operating segments. Majority of revenue comes from Network services segment which focuses India Network Business, World'wide Network Business, Wholesale Voice, Retail Voice. Network services offers Secure Connect, Express Connect, Partner Connect, Data Center/Cloud Interconnect portfolio services. It has presence in India, and Rest of world. It generates maximum revenue from India.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.